Original source text
Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent
Continued strength in Fuel Specialties and further improvement in Performance Chemicals and Oilfield Services
Debt-free balance sheet with over $250 million in net cash; $6.4 million in share repurchases
GAAP EPS $1.25 and adjusted non-GAAP EPS $1.27
ENGLEWOOD, Colo., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the second quarter ended June 30, 2026.
Total revenues for the second quarter were $491.4 million, an increase of 12 percent from $439.7 million in the corresponding period last year. Net income attributable to Innospec for the quarter was $30.8 million or $1.25 per diluted share compared to $23.5 million or 94 cents per diluted share recorded in the second quarter last year. Adjusted EBITDA for the quarter was $50.1 million compared to $49.1 million reported in the same period a year ago.
Results for this quarter include some special items, which are summarized in the table below. Excluding these items, adjusted non-GAAP EPS in the second quarter was $1.27 per diluted share, compared to $1.26 per diluted share a year ago.
Cash from operating activities was $7.2 million before capital expenditure of $16.5 million. The quarter closed with net cash of $250.2 million. In the second quarter, the Company paid its semi-annual dividend of 92 cents per common share and repurchased 87,089 of its common shares under the share repurchase program at a cost of $22.7 million and $6.4 million respectively.
Adjusted EBITDA and net income attributable to Innospec excluding special items and related per-share amounts together with net cash, are non-GAAP financial measures that are defined and reconciled with GAAP results herein and in the schedules below.
Quarter ended June 30, 2026Quarter ended June 30, 2025 (in millions, except share and per share data) Net income attributable to Innospec Diluted EPS Net income attributable to Innospec Diluted EPS Reported GAAP amounts$30.8$1.25$23.5$0.94 Foreign currency exchange (gains)/losses (0.9) (0.04) 3.5 0.14 Amortization of acquired intangible assets 0.8 0.03 1.6 0.06 Legacy costs of closed operations 0.7 0.03 2.3 0.09 Adjustment to fair value of contingent consideration 0.1 - 0.8 0.03 0.7 0.02 8.2 0.32 Adjusted non-GAAP amounts$31.5$1.27$31.7$1.26 Commenting on the second quarter results, Patrick S. Williams, President and Chief Executive Officer, said,
“This was a strong quarter for Innospec with all businesses contributing to double digit operating income growth.
Performance Chemicals operating leverage drove a 15 percent operating income increase over last year. In North Carolina we continue to advance our plant repairs, process improvements and upgrades to meet customer requirements. In parallel, we continue to execute on a range of other topline and margin opportunities identified in the business. We expect these combined efforts to drive further improvement in the second half of 2026.
Fuel Specialties had another strong quarter delivering revenue and operating income growth with margins that remained within our target range. As expected, the business continued to deliver consistently as our team advances on a broad set of regional and end-market opportunities in traditional fuel, renewable fuel and non-fuel applications.
Oilfield Services operating income and margins improved sequentially and on the prior year, driven by our recent DRA plant expansion and growing opportunities to deliver this industry-leading technology to our customers. In addition, we remain focused on driving growth and margin improvement in our US and Middle East completions and production business. We are confident that these combined efforts will drive further sequential improvement in the second half of 2026.”
Revenues in Performance Chemicals of $190.3 million were up 9 percent from $173.8 million in the second quarter of last year. Volume reductions of 2 percent were offset by a positive price/mix of 8 percent and a positive currency impact of 3 percent. Gross margins of 17.3 percent decreased by 0.2 percentage points from the same quarter last year. Operating income of $16.4 million increased 15 percent from $14.3 million in the corresponding prior year period.
Revenues in Fuel Specialties of $185.7 million were up 12 percent from $165.1 million in the second quarter of last year. Volumes were up 7 percent with price/mix up 3 percent and a positive currency impact of 2 percent. Gross margins of 36.6 percent decreased by 1.5 percentage points over last year. Operating income of $36.3 million increased 3 percent from $35.4 million a year ago.
Revenues in Oilfield Services of $115.4 million for the quarter were up 14 percent from $100.8 million in the second quarter of last year. Gross margins of 32.3 percent increased by 2.7 percentage points from the same quarter last year. Operating income of $8.7 million increased 40 percent from $6.2 million in the prior year period.
Corporate costs for the quarter were $21.6 million compared with $20.9 million a year ago.
The effective tax rate for the quarter was 25.0 percent compared to 26.0 percent in the same period last year, reflecting the geographical location of taxable profits.
For the quarter, cash provided by operating activities was $7.2 million compared to $10.5 million a year ago. As of June 30, 2026, Innospec had $250.2 million in cash and cash equivalents and no debt.
Mr. Williams concluded,
“This was a strong quarter for Innospec driven by improved performance in all our businesses. We remain focused on further technology development, topline growth and margin improvement opportunities, and we are optimistic about the impact that these actions will have on future results.
Operating cash generation was positive in the quarter, and our net cash position closed at over $250 million. We expect increased operating cash flow in the second half as we improve working capital efficiency. We continue to have significant balance sheet flexibility for organic investment, M&A, dividend growth, and buybacks. This quarter we continued our record of returning value to shareholders with our semi-annual dividend of 92 cents per share and $6.4 million in share repurchases.”
Use of Non-GAAP Financial Measures
The information presented in this press release includes financial measures that are not calculated or presented in accordance with Generally Accepted Accounting Principles in the United States (GAAP). These non-GAAP financial measures comprise adjusted EBITDA, net income attributable to Innospec excluding special items and related per share amounts together with net cash. Adjusted EBITDA is net income attributable to Innospec per our consolidated financial statements adjusted for the exclusion of interest income, net, income taxes, depreciation and amortization, foreign currency exchange (gains)/losses, legacy costs of closed operations and adjustment to fair value of contingent consideration. Net income attributable to Innospec and diluted EPS, excluding special items, per our consolidated financial statements are adjusted for the exclusion of foreign currency exchange (gains)/losses, amortization of acquired intangible assets, legacy costs of closed operations and adjustment to fair value of contingent consideration. Net cash is cash and cash equivalents less total debt. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided herein and in the schedules below.
The Company believes that such non-GAAP financial measures provide useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, these non-GAAP measures address questions the Company routinely receives from analysts and investors and the Company has determined that it is appropriate to make this data available to all investors. While the Company believes that such measures are useful in evaluating the Company’s performance, investors should not consider them to be a substitute for financial measures prepared in accordance with GAAP. In addition, these non-GAAP financial measures may differ from similarly titled non-GAAP financial measures used by other companies and do not provide a comparable view of the Company’s performance relative to other companies in similar industries. Management uses adjusted EPS (the most directly comparable GAAP financial measure for which is GAAP EPS) and net income attributable to Innospec excluding special items and adjusted EBITDA (the most directly comparable GAAP financial measure for which is GAAP net income attributable to Innospec) to allocate resources and evaluate the performance of the Company’s operations and has provided a reconciliation of adjusted EBITDA and net income attributable to Innospec excluding special items, and related per share amounts, to GAAP net income attributable to Innospec herein and in the schedules below.
About Innospec Inc.
Innospec Inc. is an international specialty chemicals company with approximately 2,450 employees in 22 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil and gas exploration and production industry.
Forward-Looking Statements
This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “could,” “believes,” “feels,” “plans,” “intends,” “outlook” or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2025, Innospec’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading "Risk Factors” in such reports. Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contacts:
Corbin Barnes
Innospec Inc.
+1-303-792-5554
[email protected]
INNOSPEC INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Schedule 1
(in millions, except share and per share data)
Three Months Ended
June 30 Six Months Ended June 302026 2025 2026 2025 Net sales$491.4$439.7$944.6$880.5Cost of goods sold (353.1) (316.5) (682.8) (632.2)Gross profit 138.3 123.2 261.8 248.3 Operating expenses: Selling, general and administrative (84.3) (74.6) (162.8) (143.9)Research and development (14.2) (13.6) (27.4) (26.3)Adjustment to fair value of contingent consideration (0.1) (0.8) 4.6 (1.5)Profit on disposal of property, plant and equipment - 0.1 - 0.2Total operating expenses (98.6) (88.9) (185.6) (171.5)Operating income 39.7 34.3 76.2 76.8Other income/(expense), net 1.1 (4.7) 3.7 (4.4)Interest income, net 0.8 2.7 1.6 5.1Income before income taxes 41.6 32.3 81.5 77.5Income taxes (10.4) (8.4) (19.5) (20.0)Net income 31.2 23.9 62.0 57.5Net income attributable to non-controlling interests (0.4) (0.4) (0.8) (1.2)Net income attributable to Innospec$30.8$23.5$61.2$56.3 Earnings per share: Basic$1.25$0.94$2.48$2.26Diluted$1.25$0.94$2.47$2.24 Weighted average shares outstanding (in thousands): Basic 24,644 24,937 24,710 24,954Diluted 24,707 25,042 24,807 25,097 INNOSPEC INC. AND SUBSIDIARIES
Schedule 2A
SEGMENTAL ANALYSIS OF RESULTS Three Months Ended June 30 Six Months Ended June 30(in millions) 2026 2025 2026 2025 Net sales: Performance Chemicals$190.3$173.8$359.7$342.2Fuel Specialties 185.7 165.1 367.3 335.4Oilfield Services 115.4 100.8 217.6 202.9 491.4 439.7 944.6 880.5 Gross profit: Performance Chemicals 33.0 30.5 61.4 65.8Fuel Specialties 68.0 62.9 132.3 123.7Oilfield Services 37.3 29.8 68.1 58.8 138.3 123.2 261.8 248.3 Operating income: Performance Chemicals 16.4 14.3 27.1 34.1Fuel Specialties 36.3 35.4 74.1 72.3Oilfield Services 8.7 6.2 14.3 10.3Corporate costs (21.6) (20.9) (43.9) (38.6) 39.8 35.0 71.6 78.1Adjustment to fair value of contingent consideration (0.1) (0.8) 4.6 (1.5)Profit on disposal of property, plant and equipment - 0.1 - 0.2Total operating income$39.7$34.3$76.2$76.8 Schedule 2B
NON-GAAP MEASURES Three Months Ended June 30 Six Months Ended June 30(in millions) 2026 2025 2026 2025 Net income attributable to Innospec$30.8$23.5$61.2$56.3Interest income, net (0.8) (2.7) (1.6) (5.1)Income taxes 10.4 8.4 19.5 20.0Depreciation and amortization 9.9 11.4 19.8 22.3Foreign currency exchange (gains)/losses (1.2) 4.7 (3.7) 4.3Legacy costs of closed operations 0.9 3.0 3.2 3.8Adjustment to fair value of contingent consideration 0.1 0.8 (4.6) 1.5Adjusted EBITDA$50.1$49.1$93.8$103.1 INNOSPEC INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
Schedule 3
(in millions)
June 30,
2026 December 31,
2025Assets Current assets: Cash and cash equivalents$250.2$292.5Trade and other accounts receivable 408.6 342.3Inventories 337.3 329.3Prepaid expenses 13.3 20.1Prepaid income taxes 5.7 13.1Other current assets 9.6 7.3Total current assets 1,024.7 1,004.6 Net property, plant and equipment 293.3 286.1Operating lease right-of-use assets 47.9 52.7Goodwill 398.2 399.0Other intangible assets 65.3 67.7Deferred tax assets 13.3 13.6Other non-current assets 3.5 8.7Total assets$1,846.2$1,832.4Liabilities and Stockholders’ Equity Current liabilities: Accounts payable$169.4$174.7Accrued liabilities 170.0 152.3Current portion of operating lease liabilities 14.3 15.9Current portion of plant closure provisions 4.9 4.9Current portion of acquisition-related contingent consideration 2.8 7.0Accrued income taxes 6.7 5.3Total current liabilities 368.1 360.1 Operating lease liabilities, net of current portion 33.6 36.8Plant closure provisions, net of current portion 59.8 60.2Deferred tax liabilities 16.0 19.1Pension liabilities and post-employment benefits 12.7 13.2Acquisition-related contingent consideration, net of current portion 1.3 1.3Other non-current liabilities 3.7 8.8Equity 1,351.0 1,332.9Total liabilities and equity$1,846.2$1,832.4 INNOSPEC INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Schedule 4
Six Months Ended
June 30(in millions) 2026 2025Cash Flows from Operating Activities Net income$62.0$57.5Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 19.9 22.0Adjustment to fair value of contingent consideration (4.6) 1.5Deferred taxes (2.7) (0.6)Profit on disposal of property, plant and equipment - (0.2)Movements on defined benefit pension plans 0.1 2.6Stock option compensation 3.8 4.1Changes in working capital (60.9) (22.6)Movements in plant closure provisions 1.1 1.4Movements in income taxes 7.2 (22.9)Movements in other assets and liabilities (1.1) (4.0)Net cash provided by operating activities 24.8 38.8 Cash Flows from Investing Activities Capital expenditures (26.6) (21.4)Proceeds on disposal of property, plant and equipment 1.5 0.5Internally developed software (5.1) (10.8)Net cash used in investing activities (30.2) (31.7) Cash Flows from Financing Activities Dividend paid (22.7) (20.8)Issue of treasury stock 0.1 0.4Repurchase of common stock (13.5) (13.3)Net cash used in financing activities (36.1) (33.7) Effect of foreign currency exchange rate changes on cash (0.8) 4.0Net change in cash and cash equivalents (42.3) (22.6)Cash and cash equivalents at beginning of period 292.5 289.2Cash and cash equivalents at end of period$250.2$266.6
